Acamprol (acamprosate) / Sun Pharma - LARVOL DELTA

Promoting Medications for Alcohol Use Disorder on the General Medicine Service (clinicaltrials.gov) - P=N/A | N=67 | Terminated | Sponsor: Yale University | Suspended ➔ Terminated; COVID-19 disrupted recruitment

Trial termination • Addiction (Opioid and Alcohol)

Pharmacogenetics of alcohol addiction: Current perspectives (Dovepress) - "In view of the importance of the precision approaches development not in addiction medicine only, but in other fields of medicine also to increase the efficacy and safety of the therapy, studies on pharmacogenetic biomarkers development for the medications used in patients with AUD (eg, naltrexone, disulfiram, nalmefene, acamprosate, etc.) remain relevant..."

Review